Latest stories on ELOX
Guggenheim initiates Eloxx Pharma stock with buy on kidney data
Investing.com Analyst Ratings61 · neutralanalyst
Eloxx’s EXACT Study Puts Exaluren in Focus for Rare Kidney Disease Investors
TipRanks59 · neutralproduct/pr
Eloxx Pharmaceuticals, Inc. Announces Pricing of $66.0 Million Public Offering and Uplisting to Nasdaq
PR Newswire24 · bearishgeneral
Eloxx Pharmaceuticals Executes Reverse Stock Split and Governance Revamp
TipRanks38 · neutralgeneral